Skip to main content
AMN
NYSE Life Sciences

Q3 Revenue Jumps 13% to $717M, but Q4 Guidance Calls for 10-12% Decline

Tom Rudovsky · Reported by Wiseek News
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$49.05
Mkt Cap
$1.837B
52W Low
$14.97
52W High
$49.62
52W Position info
228% above low
Off High info
1.1% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AMN has more than doubled off its 52-week low of $14.97.

Summary

Q3 revenue came in at $717M, up 13% year over year and 7% from Q2's $673M, with adjusted diluted EPS of $1.16 versus $0.39 a year earlier. Adjusted EBITDA rose 63% to $94M, a 13.0% margin, helped by a reserve release that lifted gross margin sequentially. The catch is the forward view: management guides Q4 revenue down 10-12% year over year, assuming only $5M of labor disruption revenue versus $124M in Q4 2025 — the comparison period is doing much of the work in both directions. Q3 also burned $88M of operating cash as the company refunded most client deposits tied to prior labor disruption events, a real cash drag behind the headline growth. Q4 results will show whether the underlying business holds up once the labor disruption tailwind is gone.

At the time of this announcement, AMN was trading at $49.05 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $14.97 to $49.62. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AMN - Latest Insights

AMN
Nov 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $49.05
Real-time Price: $47.50 info
Change: -$1.55 (-3%) info
Market Cap: $1.837B info
AMN
Aug 06, 2026, 6:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.90
Real-time Price: $47.50 info
Change: +$14.60 (+44%) info
Market Cap: $1.837B info
AMN
Jun 24, 2026, 10:42 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $31.22
Real-time Price: $47.50 info
Change: +$16.29 (+52%) info
Market Cap: $1.837B info
AMN
Jun 09, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $31.39
Real-time Price: $47.50 info
Change: +$16.11 (+51%) info
Market Cap: $1.837B info
AMN
May 07, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.96
Real-time Price: $47.50 info
Change: +$23.54 (+98%) info
Market Cap: $1.837B info